Stock-Based Compensation (Tables)
|
9 Months Ended |
Sep. 30, 2024 |
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Stock Option Activity |
Stock option activity for the nine months ended September 30, 2024 was as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Number of Options Outstanding | | Weighted-Average Exercise Price (Per share) | | Weighted-Average Remaining Life (In years) | | Aggregate Intrinsic Value (In thousands) | | Outstanding at January 1, 2024 | 3,289,019 | | | $ | 9.43 | | | 4.17 | | $ | 89,671 | | | | | | | | | | | | | | | | | | | Exercised | (1,696,804) | | | 7.03 | | | | | | | Forfeited or cancelled | (32,987) | | | 16.30 | | | | | | | Outstanding at September 30, 2024 | 1,559,228 | | | $ | 11.86 | | | 5.40 | | $ | 44,484 | | | Vested and exercisable at September 30, 2024 | 1,526,692 | | | 11.72 | | | 5.38 | | 43,777 | | | Vested and unvested expected to vest at September 30, 2024 | 1,558,803 | | | $ | 11.86 | | | 5.40 | | $ | 44,475 | |
|
| Schedule of RSU Activity |
RSU activity for the nine months ended September 30, 2024 was as follows: | | | | | | | | | | | | | Shares | | Weighted-Average Grant Date Fair Value (Per share) | | Unvested balance at January 1, 2024 | 6,308,499 | | | $ | 36.07 | | | Granted | 2,983,779 | | | 37.09 | | | Vested | (1,641,401) | | | 37.38 | | | Forfeited or cancelled | (1,889,799) | | | 36.02 | | | Unvested balance at September 30, 2024 | 5,761,078 | | | 36.23 | | | Vested and expected to vest at September 30, 2024 | 4,833,171 | | | $ | 36.17 | |
|
| Schedule of PRSU Activity |
The Company has issued PRSUs which vest based on the achievement of each award’s established performance targets. PRSU activity for the nine months ended September 30, 2024 was as follows: | | | | | | | | | | | | | | | Shares | | Weighted-Average Grant Date Fair Value (Per share) | | | | Unvested balance at January 1, 2024 | 537,715 | | | $ | 35.25 | | | | | Granted | 168,944 | | | 36.48 | | | | | Vested | (96,469) | | | 51.25 | | | | | Forfeited or cancelled | (98,833) | | | 31.75 | | | | | Adjusted by performance factor | (305,948) | | | 31.75 | | | | | Unvested balance at September 30, 2024 | 205,409 | | | $ | 35.64 | | | | | | | | | |
|
| Summary of Share-Based Payment Arrangement and Price Targets |
A cumulative percentage of the MRSU target is earned based on the achievement of stock price goals, measured based on the average of the Company’s closing stock price over a consecutive 60 trading day period during the performance period as set forth in the table below: | | | | | | | | | | | | | | | | | | Tranche | | Company Stock Price Target | | Total Payout | | | | 1 | | $65.00 | | 25% of Target MRSUs | | | | 2 | | $100.00 | | 50% of Target MRSUs | | | | 3 | | $135.00 | | 100% of Target MRSUs | | | | 4 | | $170.00 | | 150% of Target MRSUs | | |
|
| Summary of Stock-Based Compensation Expense |
Stock-based compensation is included in the Condensed Consolidated Statements of Operations as follows: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | September 30, | | September 30, | | 2024 | | 2023 | | 2024 | | 2023 | | Cost of revenue | $ | 506 | | | $ | 497 | | | $ | 1,583 | | | $ | 1,350 | | | Research and development | 10,828 | | | 9,502 | | | 29,099 | | | 35,280 | | | Sales and marketing | 2,063 | | | 4,701 | | | 9,105 | | | 11,759 | | General and administrative (1) | 9,552 | | | (17,071) | | | 27,872 | | | 13,263 | | | Restructuring and other charges | — | | | — | | | — | | | 3,937 | | | Total | $ | 22,949 | | | $ | (2,371) | | | $ | 67,659 | | | $ | 65,589 | | | | | | | | | |
(1) Amount includes $31.3 million of recognized stock-based compensation related to our former CEO’s MRSUs that was estimated to be forfeited and therefore reversed for the three and nine months ended September 30, 2023.
|